B Antigen Cer (d20:1/24:1) is a glycolipid subtype, which can be used as a useful glycosphingolipid standard in the research of the mechanisms of cancer occurrence and development.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.